Arcus Biosciences Inc (RCUS) — Financial Flexibility Index
Arcus Biosciences Inc (RCUS) has a Financial Flexibility Index of -0.29x as of March 2026. Free cash flow of $-138.00 Million (operating CF $-138.00 Million minus capex $0.00) represents 0% of total liabilities ($473.00 Million). Check Arcus Biosciences Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arcus Biosciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Arcus Biosciences Inc across 10 annual periods. See working capital to net assets of Arcus Biosciences Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Arcus Biosciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Arcus Biosciences Inc. For the full company profile including market capitalisation, see RCUS market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-480.00 Million | $-482.00 Million | $508.00 Million | ▼ -283.1% |
| 2024 | -0.25x | $-164.00 Million | $-170.00 Million | $665.00 Million | ▲ +44.6% |
| 2023 | -0.45x | $-282.00 Million | $-306.00 Million | $633.00 Million | ▼ -169.0% |
| 2022 | 0.65x | $444.00 Million | $438.00 Million | $688.00 Million | ▲ +310.5% |
| 2021 | -0.31x | $-230.09 Million | $-256.17 Million | $750.45 Million | ▼ -172.5% |
| 2020 | 0.42x | $114.22 Million | $111.17 Million | $269.99 Million | ▲ +123.2% |
| 2019 | -1.82x | $-71.54 Million | $-73.46 Million | $39.27 Million | ▼ -85.6% |
| 2018 | -0.98x | $-39.25 Million | $-43.00 Million | $39.98 Million | ▼ -83.9% |
| 2017 | -0.53x | $-19.55 Million | $-25.06 Million | $36.62 Million | ▲ +38.2% |
| 2016 | -0.86x | $-8.85 Million | $-12.94 Million | $10.24 Million | — |